Cargando…
Shattering the castle walls: Anti-stromal therapy for pancreatic cancer
Despite the availability of potent chemotherapy regimens, such as 5-fluorouracil, folinic acid, irinotecan, and oxaliplatin (FOLFIRINOX) and nab-paclitaxel plus gemcitabine, treatment outcomes in metastatic pancreatic cancer (PC) remain unsatisfactory. The presence of an abundant fibrous stroma in P...
Autores principales: | Kanat, Ozkan, Ertas, Hulya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107476/ https://www.ncbi.nlm.nih.gov/pubmed/30147846 http://dx.doi.org/10.4251/wjgo.v10.i8.202 |
Ejemplares similares
-
Existing anti-angiogenic therapeutic strategies for patients with metastatic colorectal cancer progressing following first-line bevacizumab-based therapy
por: Kanat, Ozkan, et al.
Publicado: (2019) -
Contemporary treatment approaches for metastatic colorectal cancer driven by BRAF V600 mutations
por: Kanat, Ozkan, et al.
Publicado: (2020) -
Dual HER2 inhibition strategies in the management of treatment-refractory metastatic colorectal cancer: History and status
por: Kanat, Ozkan, et al.
Publicado: (2018) -
Platinum-induced neurotoxicity: A review of possible mechanisms
por: Kanat, Ozkan, et al.
Publicado: (2017) -
Breaching the Castle Walls: Hyaluronan Depletion as a Therapeutic Approach to Cancer Therapy
por: Shepard, H. Michael
Publicado: (2015)